OncLive | Bringing the Global Oncology Community Together

The oral multi-kinase inhibitor regorafenib extended progression-free survival in patients with metastatic or unresectable biliary tract cancer who were previously treated with gemcitabine and a platinum-based chemotherapy. Read More >>

SGO WINTER 2019: Westin Highlights the Evolving Role of PARP Inhibitors in Ovarian Cancer

GI 2019: Dabrafenib/Trametinib Combo Induces High Responses in BRAF V600E-Mutant Biliary Tract Cancer

GI 2019: SM-88 Achieves Encouraging Clinical Benefit Rate in Metastatic Pancreatic Cancer

SGO WINTER 2019: Investigators Still Seeking Options Beyond PARP Inhibitors in Ovarian Cancer

SGO WINTER 2019: Immunotherapy Agents Could Improve Survival in Advanced Cervical Cancer

View More Stories >>

View Conference Coverage

2019 Transplantation and Cellular Therapy Meetings

2019 Winter Lung Cancer Conference

2019 SGO Winter Meeting

2019 Gastrointestinal Cancers Symposium

2018 State of the Science Summit on Advanced NSCLC

Dr. Llovet Discusses Second-Line Ramucirumab in Advanced HCC

Dr. Suarez Mora On Sequential Sampling of IP Fluid During Chemotherapy

Dr. Essel on Quantitative Computed Tomography Image Feature Analysis in Gynecologic Cancers

Dr. Molena on Challenges With Endoscopic Resection in Esophageal Cancers

$Dr. Chari on Treatment of Penta-Refractory Patients With Myeloma$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Risk Assessment in Follicular Lymphoma

Diagnosis and Prognosis of Follicular Lymphoma

Considerations for Treating Patients with CDK4/6 Inhibitors

CDK4/6 Inhibitors in Metastatic Breast Cancer

Treating Newly Diagnosed High-Risk Smoldering Myeloma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Mantle Cell Lymphoma: Impact of Genetic Variants

Understanding the Heterogeneity of Mantle Cell Lymphoma

Progress in the Treatment of Multiple Myeloma

Glasdegib, Gilteritinib, and Quizartinib Against AML

Venetoclax for CLL After Progression on 1 Prior Therapy

Monoclonal Antibody, Triplet Therapy & Transplant Ineligible

Relapse Therapy: Incremental Change Versus Different Regimen

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>